Research tools and platforms in the Bio-Link portfolio that are available for licensing and partnership include the following:

Akimba: A Novel Murine Model for Diabetic Retinopathy

The Akimba model developed at the Lions Eye Institute is useful to elucidate the pathophysiology of diabetic retinopathy (DR). Biopharmaceutical companies can use Akimba to study how two important factors; hyperglycemia and vascular endothelial growth factor (VEGF), interact in DR and to test their drug candidates in this murine model.

Summary (PDF)